270 related articles for article (PubMed ID: 33453002)
21. Stereotactic body radiation therapy for benign spine tumors: is dose de-escalation appropriate?
Kalash R; Glaser SM; Flickinger JC; Burton S; Heron DE; Gerszten PC; Engh JA; Amankulor NM; Vargo JA
J Neurosurg Spine; 2018 Aug; 29(2):220-225. PubMed ID: 29799334
[TBL] [Abstract][Full Text] [Related]
22. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes.
Bernard V; Bishop AJ; Allen PK; Amini B; Wang XA; Li J; Tatsui CE; Rhines LD; Brown PD; Ghia AJ
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1207-1215. PubMed ID: 29029886
[TBL] [Abstract][Full Text] [Related]
23. CT based quantitative measures of the stability of fractured metastatically involved vertebrae treated with spine stereotactic body radiotherapy.
Hardisty M; Wright T; Campbell M; Burke M; Atenafu E; Cawricz M; Caldwell C; Yee A; Sahgal A; Whyne C
Clin Exp Metastasis; 2020 Oct; 37(5):575-584. PubMed ID: 32643007
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Body Radiotherapy (SBRT) for Spinal Metastases: Who Will Benefit the Most from SBRT?
Park HJ; Kim HJ; Won JH; Lee SC; Chang AR
Technol Cancer Res Treat; 2015 Apr; 14(2):159-67. PubMed ID: 24502552
[TBL] [Abstract][Full Text] [Related]
25. Oligometastatic Disease State Is Associated with Improved Local Control in Patients Undergoing Three or Five Fraction Spine Stereotactic Body Radiotherapy.
Silva SR; Gliniewicz A; Martin B; Prabhu VC; Germanwala AV; Melian E; Jones GA; Solanki AA
World Neurosurg; 2019 Feb; 122():e342-e348. PubMed ID: 30326310
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of different fractions in stereotactic body radiotherapy for spinal metastases: A systematic review.
Gong Y; Xu L; Zhuang H; Jiang L; Wei F; Liu Z; Li Y; Yu M; Ni K; Liu X
Cancer Med; 2019 Oct; 8(14):6176-6184. PubMed ID: 31489788
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of stereotactic body radiotherapy as primary treatment for vertebral metastases: a multi-institutional analysis.
Guckenberger M; Mantel F; Gerszten PC; Flickinger JC; Sahgal A; Létourneau D; Grills IS; Jawad M; Fahim DK; Shin JH; Winey B; Sheehan J; Kersh R
Radiat Oncol; 2014 Oct; 9():226. PubMed ID: 25319530
[TBL] [Abstract][Full Text] [Related]
28. Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system.
Giaj-Levra N; Niyazi M; Figlia V; Napoli G; Mazzola R; Nicosia L; Corradini S; Ruggieri R; Minniti G; Alongi F
Radiat Oncol; 2019 Oct; 14(1):184. PubMed ID: 31655620
[TBL] [Abstract][Full Text] [Related]
29. 30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel Regimen.
Moore-Palhares D; Sahgal A; Zeng KL; Myrehaug S; Tseng CL; Detsky J; Chen H; Ruschin M; Atenafu EG; Wilson J; Larouche J; da Costa L; Maralani PJ; Soliman H
Neurosurgery; 2023 Oct; 93(4):813-823. PubMed ID: 37074052
[TBL] [Abstract][Full Text] [Related]
30. Utility of expanded anterior column resection versus decompression-alone for local control in the management of carcinomatous vertebral column metastases undergoing adjuvant stereotactic radiotherapy.
Pennington Z; Pairojboriboon S; Chen X; Sacino A; Elsamadicy AA; de la Garza Ramos R; Patel J; Elder BD; Kleinberg LR; Sciubba DM; Redmond KJ; Lo SL
Spine J; 2022 May; 22(5):835-846. PubMed ID: 34718175
[TBL] [Abstract][Full Text] [Related]
31. Vertebral Fractures Following Stereotactic Body Radiotherapy for Spine Oligometastases: A Multi-institutional Analysis of Patient Outcomes.
Abbouchie H; Chao M; Tacey M; Joon DL; Ho H; Guerrieri M; Ng M; Foroudi F
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):433-441. PubMed ID: 32169302
[TBL] [Abstract][Full Text] [Related]
32. Patterns of epidural progression following postoperative spine stereotactic body radiotherapy: implications for clinical target volume delineation.
Chan MW; Thibault I; Atenafu EG; Yu E; John Cho BC; Letourneau D; Lee Y; Yee A; Fehlings MG; Sahgal A
J Neurosurg Spine; 2016 Apr; 24(4):652-9. PubMed ID: 26682603
[TBL] [Abstract][Full Text] [Related]
33. Stereotactic body radiotherapy for bone metastases in patients with colorectal cancer.
Ito K; Yamaguchi T; Ogawa H; Nakajima Y; Karasawa K
Jpn J Clin Oncol; 2020 Dec; 50(12):1442-1446. PubMed ID: 32719860
[TBL] [Abstract][Full Text] [Related]
34. The impact of decompression with instrumentation on local failure following spine stereotactic radiosurgery.
Miller JA; Balagamwala EH; Berriochoa CA; Angelov L; Suh JH; Benzel EC; Mohammadi AM; Emch T; Magnelli A; Godley A; Qi P; Chao ST
J Neurosurg Spine; 2017 Oct; 27(4):436-443. PubMed ID: 28731393
[TBL] [Abstract][Full Text] [Related]
35. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
Myrehaug S; Sahgal A; Hayashi M; Levivier M; Ma L; Martinez R; Paddick I; Régis J; Ryu S; Slotman B; De Salles A
J Neurosurg Spine; 2017 Oct; 27(4):428-435. PubMed ID: 28708043
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for spine metastases: a review of 24 Gy in 2 daily fractions.
Nguyen EK; Ruschin M; Zhang B; Soliman H; Myrehaug S; Detsky J; Chen H; Sahgal A; Tseng CL
J Neurooncol; 2023 May; 163(1):15-27. PubMed ID: 37155133
[TBL] [Abstract][Full Text] [Related]
37. Risk-adapted stereotactic body radiotherapy for patients with cervical spinal metastases.
Wang HH; Tian SS; Yang JM; Sun BS; Chen Y; Song YC; Dong Y; Wang JS; Yuan ZY; Cui YL; Meng MB
Cancer Sci; 2022 Dec; 113(12):4277-4288. PubMed ID: 36056609
[TBL] [Abstract][Full Text] [Related]
38. Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control.
Abugharib A; Zeng KL; Tseng CL; Soliman H; Myrehaug S; Husain Z; Maralani PJ; Larouche J; Cheung P; Emmenegger U; Atenafu EG; Sahgal A; Detsky JS
Neurosurgery; 2022 Jun; 90(6):743-749. PubMed ID: 35343467
[TBL] [Abstract][Full Text] [Related]
39. Radiosurgery or hypofractionated stereotactic radiotherapy for brain metastases from radioresistant primaries (melanoma and renal cancer).
Lesueur P; Lequesne J; Barraux V; Kao W; Geffrelot J; Grellard JM; Habrand JL; Emery E; Marie B; Thariat J; Stefan D
Radiat Oncol; 2018 Jul; 13(1):138. PubMed ID: 30055640
[TBL] [Abstract][Full Text] [Related]
40. Surgical resection of epidural disease improves local control following postoperative spine stereotactic body radiotherapy.
Al-Omair A; Masucci L; Masson-Cote L; Campbell M; Atenafu EG; Parent A; Letourneau D; Yu E; Rampersaud R; Massicotte E; Lewis S; Yee A; Thibault I; Fehlings MG; Sahgal A
Neuro Oncol; 2013 Oct; 15(10):1413-9. PubMed ID: 24057886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
